AzTrials
AzTrials

Tooth ImpactedOTTO-SYSTNCT03048175

Acute Inflammation After Wisdom Tooth Removal

A study testing Wisdom tooth removal in people with Tooth Impacted, run by University of Pisa.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Third molar (wisdom teeth) extraction is one of the most frequent intervention in dentistry. Nevertheless, little is known about the level of general body inflammation of subjects with impacted or semi-impacted third molars. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Tooth Impacted
What is being tested?
Wisdom tooth removal
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
No sites listed yet
Study dates
19 Apr 2007to 30 Jun 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • cases: bilateral wisdom tooth pathology.
  • control: agenesia/previous extraction/no symptoms of the lower third molars.

Who cannot join

  • younger than 18 years and older than 65 years;
  • pregnant or lactating females;
  • females using contraceptive methods;
  • suffering from any systemic illness;
  • undergoing any pharmacological treatment within 30 days prior to the inclusion
  • patients affected by periodontal disease (radiographic diagnosis of vertical bone defects or bone resorption equal to 20% of the root length);
  • patients with periapical and periradicular radiolucent areas X-ray detectable;
  • patients unable to participate to study.

About this study

Official title: Systemic Inflammation After Wisdom Tooth Removal: a Case-control Study

Third molar (wisdom teeth) extraction is one of the most frequent intervention in dentistry. Nevertheless, little is known about the level of general body inflammation of subjects with impacted or semi-impacted third molars. Moreover, The possible effects of surgical removal of wisdom teeth on the overall health are not known.

Thus, a study in which 40 subjects has been designed. Twenty subjects were affected by bilateral wisdom tooth pathology necessitating for extraction of both teeth. Control group comprised 20 subjects with absence of wisdom teeth or completely erupted wisdom teeth without pathology associated to or history of previous extraction of both wisdom teeth.

Read more

In both groups a medical and dental examination will be performed at the baseline and 3 months after baseline for the control group or after the second third molar extraction in the control group. Blood will be also withdrawn to assess systemic inflammation and other systemic parameters.

Parameter were evaluated via high sensitive c reactive protein (CRP), lipids, fibrinogen, oxidative stress and endothelial function analysis.

Read the detailed description

Third molar extraction is one of the most frequent intervention in dentistry. Nevertheless, little is known about the systemic aspect of subjects with impacted or semi-impacted third molars and the possible effects of surgical removal on their systemic parameters. A case-control study of 40 subjects has been designed to evaluate i) the overall systemic inflammation and metabolism of subjects with bilateral third molars compared to subjects with no third molars and ii) the effect of bilateral removal in the immediate and medium postsurgical period. Systemic parameters are evaluated via high sensitive c reactive protein (CRP), lipids, fibrinogen, oxidative stress and endothelial function analysis.

Conditions
Tooth Impacted
Being tested
Wisdom tooth removal
Keywords
C-reactive protein, Systemic inflammation, Third molar, Wisdom tooth
Medical subject headings
Tooth, Impacted

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Wisdom tooth removalProcedure or surgery

    After inferior dental and buccal nerve anesthesia a triangular full thickness flap with releasing incision on the mesio-buccal aspect of the second molar is designed. Ostectomy is then performed and tooth is sectioned and gently elevated. Once all the tooth components are extracted, the socket is carefully inspected and flap is sutured with interrupted sutures.

Study groups in NCT03048175
Study groupRoleWhat they receive
Cases: wisdom tooth pathologyExperimentalSubjects affected by bilateral wisdom tooth pathology, undergoing surgical removal
Receives: Procedure: Wisdom tooth removal
Controls: no wisdom tooth pathologyNo interventionSubjects showing agenesia/previous extraction/no symptoms of the lower third molars.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in C-reactive protein (CRP)

    High-Sensitive plasmatic C-reactive protein

    Measured: baseline, 24 and three months after the second extraction

Secondary outcomes (4)
  1. Changes in plasma malondialdehyde (MDA)

    plasma malondialdehyde

    Measured: baseline, 24 and three months after the second extraction

  2. Changes in lipoperoxides (LOOH)

    lipoperoxides levels in plasma

    Measured: baseline, 24 and three months after the second extraction

  3. Changes in ferric-reducing antioxidant power (FRAP)

    FRAP levels in plasma

    Measured: baseline, 24 and three months after the second extraction

  4. Changes in endothelial flow-mediated dilation (FMD) calculated as maximal percentual increase in diameter of the blood vessel above baseline

    Endothelium-dependent response of the brachial artery in response to increased blood flow by high resolution ultrasound with a 7.5 MHz linear array transducer

    Measured: baseline, 24 and three months after the second extraction

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Feb 2017 (estimated)
  2. Study start19 Apr 2007
  3. Primary completion15 Jun 2009
  4. Study completion30 Jun 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Case-control intervention trial: cases are treated for pathology. Controls do not have pathology.
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03048175
Sponsor's protocol ID
2198
Acronym
OTTO-SYST
Status last verified
Feb 2017
First submitted
6 Feb 2017
Last updated
9 Feb 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Graziani F, D'Aiuto F, Gennai S, Petrini M, Nisi M, Cirigliano N, Landini L, Bruno RM, Taddei S, Ghiadoni L. Systemic Inflammation after Third Molar Removal: A Case-Control Study. J Dent Res. 2017 Dec;96(13):1505-1512. doi: 10.1177/0022034517722775. Epub 2017 Jul 31.

    PubMed 28759304

Questions about this trial

What is this clinical trial studying?

A study testing Wisdom tooth removal in people with Tooth Impacted, run by University of Pisa.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in C-reactive protein (CRP) (time frame: baseline, 24 and three months after the second extraction). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03048175, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in